[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
May 2004

Eruptive Xanthomas Associated With Protease Inhibitor Therapy

Arch Dermatol. 2004;140(5):617-618. doi:10.1001/archderm.140.5.617-b

In a recent report concerning eruptive xanthomas secondary to olanzapine use,1 the authors stated that, to their knowledge, there were no reports of eruptive xanthomas associated with retroviral protease inhibitors. We describe 2 cases of eruptive xanthomas in human immunodeficiency virus (HIV)–positive patients that developed after initiation of ritonavir-based highly active antiretroviral therapy (HAART).

First Page Preview View Large
First page PDF preview
First page PDF preview
×